Each title and source link reviewed
Dunaliella research
Explore the science behind Dunaliella.
Browse related publications, human research and registered clinical work in one place. We label the study model clearly and identify HETCHYN’s role only where the public source does so.
- 39 related papers
- 7 research areas
- Registered clinical study
Research hub definition
What is the HETCHYN research hub?
The HETCHYN research hub is a curated evidence-navigation resource for literature related to Dunaliella species, natural beta-carotene mixtures and 9-cis beta-carotene. It separates 39 published papers from the NCT07509229 registered protocol, classifies the study model, links to original public sources and states HETCHYN's role only where a source establishes it. Inclusion provides research context; it does not turn a related paper into a claim for Carovive® or a customer's finished product.
- Classified papers
- 39
- Research areas
- 7
- Review owner
- Research review by HETCHYN Scientific & Technical Team
| Evidence record | What it can show | What it cannot show by itself |
|---|---|---|
| Published human study | Findings for the studied population, material, dose and design | Automatic applicability to another ingredient or finished product |
| Animal or cell study | Preclinical mechanisms and directions for later research | Human efficacy or clinical substantiation |
| Registered protocol | Planned design, sponsor, intervention and current registry status | Completed outcomes before results are published |
From retinal science to healthy ageing
Separated from preclinical evidence
NCT07509229 at Sheba Medical Center
How to read the research
First check who or what was studied.
This collection maps published science related to Dunaliella species, algal extracts, natural beta-carotene mixtures and 9-cis beta-carotene. Inclusion does not mean every paper studied a HETCHYN ingredient, a Carovive® product or a finished commercial formulation.
Human study
Research involving participants or human-derived samples. Study design, population and material identity still determine what can be concluded.
Animal model
In vivo preclinical research. These findings can guide mechanisms and study design but are not human efficacy evidence.
Cell or tissue model
In vitro or ex vivo research used to examine pathways and biological responses under controlled experimental conditions.
Mixed preclinical
Research combining more than one preclinical model, such as cell and animal work, without becoming clinical evidence.
Reading boundary
Start with the evidence model, then check the species or material, dose, comparator, population and study sponsor. Related literature supports scientific review; it does not automatically establish a claim for HETCHYN ingredients or a customer’s finished product.
Evidence reading flow
How to evaluate a Dunaliella research record in four steps.
This reading order prevents a preclinical mechanism, a published human finding and a registered protocol from being treated as equivalent evidence.
Browse classified papers- 01Step 1 · Evidence model
Identify who or what was studied
Start by classifying the record as a human study, animal model, cell or tissue model, or mixed preclinical study.
- 02Step 2 · Material
Confirm the species and test material
Check whether the study used a Dunaliella species, whole algae, an extract, a carotenoid fraction or a defined beta-carotene isomer profile.
- 03Step 3 · Study design
Read dose, comparator and endpoints
Review the population or model, dose, duration, comparator and measured endpoints before interpreting the reported outcome.
- 04Step 4 · Claim boundary
Separate the finding from the product claim
Limit the conclusion to the studied material and design, then verify any HETCHYN role or finished-product claim through its own source.
Where to begin
Choose between published papers and clinical research.
The two sections separate completed findings from registered study plans, making it easier to understand what has been published and where HETCHYN is involved.
01 · Publication library
Related papers
Search and filter 39 papers by research area and evidence type. Each record includes a concise study summary and verified source link.
Browse all papers →02 · Human researchClinical research
Follow the completed 2013 human study and the registered Phase 1/2 protocol that names HETCHYN as manufacturer of the active softgel.
Review the evidence path →Research areas
Seven themes across the Dunaliella literature.
These studies cover Dunaliella species, algal extracts, natural beta-carotene mixtures and 9-cis beta-carotene. They provide relevant scientific context; they are not all HETCHYN-sponsored research.
018
Vision & retinal science
Human and preclinical work on retinal function, retinoid-cycle disorders and 9-cis beta-carotene.
→028Cardiovascular health
Cholesterol transport, macrophage biology, atherosclerosis models and human lipid observations.
→034Metabolic health
Glucose regulation, adipose inflammation, LDL oxidation and high-fat-diet models.
→043Neurodegenerative research
Cell and animal studies examining cognition, neuroinflammation and neuronal stress.
→054Oxidative stress & healthy ageing
Antioxidant, mitochondrial, lifespan and radiation-exposure research across several models.
→065Oncology research
Early-stage cell and animal research on Dunaliella extracts across selected tumour models.
→077Inflammation, liver & skin
Human and preclinical work spanning psoriasis, inflammation, liver injury and skin ageing.
→
Scientific leadership
Research reviewed with applied microalgae expertise.
Chief Scientist Professor Patricia Harvey brings long-term work across microalgae, Dunaliella, biorefineries, cellular metabolic pathways and sustainable production of high-value biological compounds.
University profileRegistered clinical work
HETCHYN manufactures the active Dunaliella softgel used in NCT07509229.
ClinicalTrials.gov lists NCT07509229 as a registered Phase 1/2 study sponsored by Sheba Medical Center and names HETCHYN as manufacturer of the active softgel.
Review the clinical recordResearch FAQ
Questions about using the research library.
The library supports scientific orientation and source tracing. It does not replace product-specific technical, regulatory or clinical substantiation.
01Does every listed paper study HETCHYN or Carovive®?
No. The collection includes related research on Dunaliella species, algal materials and natural beta-carotene profiles. A paper is connected to HETCHYN or Carovive® only when the publication, registry or another approved public source explicitly establishes that relationship.
02Can animal or cell findings be presented as human efficacy?
No. Animal, cell, tissue and mixed preclinical studies can inform mechanisms and future study design, but they are not human efficacy evidence. The evidence label on each paper should remain attached whenever its findings are summarized.
03How are publication links checked?
Each record is matched against its title, authors, journal, year and DOI or PubMed destination. The external link opens the publication record so readers can review the original source and study design.
04What is HETCHYN’s role in the registered Sheba study?
The ClinicalTrials.gov record names Sheba Medical Center as sponsor and identifies Hetchyn Ingredients Biotechnology Co., Ltd. as manufacturer of the active Dunaliella softgel. The website does not expand that documented manufacturing role into sponsorship or an efficacy claim.
05Can I request a focused paper set for one research area?
Yes. Share the research question, evidence model and intended ingredient or dosage format. HETCHYN can help organize relevant references alongside the applicable ingredient documentation, while keeping literature context separate from product qualification.
ScopeResearch hub scope and evidence classification
Verification sourcesDOI records · PubMed · ClinicalTrials.gov
Talk to our ingredient team
Discuss a research or technical collaboration.
Share the research question, target ingredient profile, dosage format and documentation needs. We can help define an appropriate supply route.
Start a research inquiry